Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
12%
Acetylsalicylic Acid
10%
Acute Coronary Syndrome
31%
Adverse Drug Reaction
23%
Adverse Event
25%
Amphetamine
11%
Antibiotic Resistance
18%
Antibiotics
11%
Anticoagulant Agent
31%
Antidepressant
10%
Antiinfective Agent
38%
Antimicrobial Agent
40%
Antiplatelet
29%
Artery Thrombosis
8%
Atrial Fibrillation
20%
Base
10%
Biological Marker
17%
Bleeding
15%
Cannabinoid
19%
Cannabis
17%
Cardiovascular Disease
16%
Cardiovascular Risk
8%
Cathinone
11%
Cell Culture
9%
Cerebrovascular Accident
10%
Chemical Warfare Agent
15%
Chronic Kidney Failure
11%
Clinical Trial
13%
Coronary Artery Disease
12%
Dendrimer
11%
Diabetes Mellitus
13%
Diamorphine
12%
Diseases
45%
Dopamine
11%
Dosage Forms
9%
Drug Dependence
20%
Drug Development
9%
Drug Information
12%
Drug Release
14%
Dry Powder Inhaler
18%
Dyskinesia
9%
End Stage Renal Disease
9%
Enzymes
13%
Excipient
13%
Fatality
31%
Fibrinolytic Agent
13%
Heart Infarction
16%
Hemodialysis
50%
Hyaluronic Acid
11%
Hydrophile
8%
Infection
21%
Inflammation
12%
Inflammatory Arthritis
12%
Ketamine
20%
Lactose
13%
Lipid
13%
Malignant Neoplasm
20%
MDMA
10%
Medication Error
9%
Mephedrone
13%
Microparticle
11%
Microsphere
8%
Mitragyna speciosa
10%
Nanoparticle
11%
Observational Study
13%
Opiate
16%
Pandemic
15%
Parkinson's Disease
9%
Penetration Enhancing Agent
10%
Peptide
13%
Pharmacokinetics
21%
Pharmacotherapy
20%
Pharmacovigilance
21%
Pig
12%
Placebo
13%
Pregabalin
8%
Prescription Drug
11%
Prevalence
29%
Prostate Cancer
17%
Psychoactive Substance
68%
Psychosis
9%
Psychotropic Agent
14%
Randomized Controlled Trial
22%
Rat
46%
Receptor
17%
Recreational Drug
9%
Rheumatoid Arthritis
12%
Salmeterol Xinafoate
12%
Side Effect
25%
Simvastatin
8%
ST Segment Elevation Myocardial Infarction
13%
Streptozotocin
14%
Sulfur Mustard
13%
Tablet
29%
Thrombosis
27%
Thrombus
16%
Ticagrelor
10%
Topical Agent
9%
Toxic Injury
29%
Toxicology
10%
Keyphrases
95% Confidence Interval
11%
Acute Care Setting
11%
Acute Coronary Syndrome
14%
Addiction
10%
Alcohol
9%
Antibiotic Prescribing
32%
Antibiotic Use
23%
Antibiotics
25%
Antimicrobial
16%
Antimicrobial Resistance
86%
Antimicrobial Resistance Surveillance
8%
Antimicrobial Stewardship
100%
Antimicrobial Stewardship Program
25%
Antimicrobial Use
13%
Anxiety Disorders
8%
Atrial Fibrillation
9%
Australia
9%
Benzodiazepines
10%
Canada
8%
Carers
8%
Chronic Kidney Disease
15%
Clinical Outcomes
9%
Clinical Practice
14%
Cocaine
10%
Comorbidity
13%
COVID-19
98%
Decontamination
8%
Depressive Symptoms
11%
Diabetes
14%
Dialysis
24%
Drug Misuse
9%
Drug-likeness
8%
Early Rheumatoid Arthritis
12%
Ecstasy
9%
Elderly Patients
8%
Epilepsy
15%
Exclusion Criteria
10%
Extracellular Vesicles
13%
Fatality
18%
Fitness to Practise
8%
Health-related Quality of Life
9%
Healthcare
10%
Healthcare Professionals
28%
Healthcare Settings
18%
Hemodiafiltration
8%
Hemodialysis
35%
Hemodialysis Patients
19%
Hertfordshire
10%
High Risk
8%
Human Skin
9%
Inception Cohort
12%
Italy
9%
Kidney Care
9%
Legal Highs
9%
Lockdown
9%
Low-middle Income Countries
10%
Major Depressive Disorder
9%
MEDLINE
10%
Mephedrone
8%
Meta-analysis
31%
Microvesicles
19%
National Survey
8%
New Psychoactive Substances
18%
NHS Trusts
18%
Non-muscle Invasive Bladder Cancer (NMIBC)
13%
Novel Psychoactive Substances
51%
Obsessive-compulsive Disorder
48%
Older Adults
10%
Older People
9%
Patient Experience
10%
Patient Outcomes
10%
Patient Safety
10%
Patient-reported Experience Measures
10%
Percutaneous Coronary Intervention
12%
Pharmacist
31%
Pharmacokinetics
10%
Pharmacy
14%
Physical Activity
9%
Posters
10%
Problematic Internet Use
10%
Public Health Risk
8%
PubMed
8%
Quality of Life
18%
Randomized Controlled Trial
23%
Residual Renal Function
14%
Respiratory Infection
8%
Rheumatoid Arthritis
22%
Saudi Arabia
9%
Scoping Review
11%
Secondary Care
20%
Stewardship
27%
Stimulants
12%
Streptozotocin
11%
Synthetic Cannabinoids
12%
Systematic Literature Review
10%
Treatment Strategy
8%
United Kingdom
30%
WHO AWaRe
8%
World Wide Web
15%
Young People
14%
Medicine and Dentistry
Acute Coronary Syndrome
9%
Acute Kidney Injury
7%
Adolescence
8%
Adverse Event
10%
Antibiotic Resistance
22%
Anticoagulation
11%
Antiinfective Agent
6%
Antimicrobial Agent
23%
Antimicrobial Stewardship
32%
Antiplatelet
8%
Antithrombotic
14%
Antithrombotic Therapy
8%
Arm
12%
Artificial Intelligence
13%
Atrial Fibrillation
13%
Awareness
11%
Biological Marker
17%
Biopsy Technique
10%
Bladder Cancer
23%
Bleeding
16%
Cardiovascular Disease
8%
Cardiovascular System
10%
Chronic Kidney Disease
28%
Clinical Trial
10%
Clinician
21%
Cohort Effect
7%
Comorbidity
22%
Coronary Artery Disease
9%
COVID-19
38%
Creatinine
6%
Cystectomy
25%
DAS28
8%
Decision Making
15%
Dermatology
10%
Diabetes
14%
Diabetes Mellitus
11%
Disease Activity
14%
Diseases
47%
Drug Therapy
10%
Education
10%
Elderly Patient
10%
End Stage Renal Disease
20%
Fibrinolysis
7%
Geriatrics
6%
Health Care Cost
20%
Health Technology
7%
Heart Arrest
7%
Hemodiafiltration
8%
Hemodialysis
60%
In Vitro
8%
Infection
15%
Inflammation
10%
Inflammatory Arthritis
33%
Kidney Function
22%
Kidney Transplantation
10%
Low and Middle Income Countries
7%
Malignant Neoplasm
8%
Mental Health
14%
Meta-Analysis
27%
Mixed Methods
7%
Morbidity
7%
Muscle Invasive Bladder Cancer
7%
Myocardial Infarction
7%
Neoadjuvant Chemotherapy
11%
Nephropathy
14%
Neurodevelopmental Disorder
7%
Observational Study
11%
Obsessive Compulsive Disorder
21%
Odds Ratio
7%
Oral
16%
Orthopedic Surgery
7%
Outpatient
9%
Overall Survival
7%
Patient Experience
15%
Patient Referral
10%
Patient-Reported Outcome
8%
Percutaneous Coronary Intervention
12%
Peritoneal Dialysis
10%
Physical Activity
10%
Pneumoperitoneum
8%
Prevalence
21%
Prostate Cancer
16%
Prostatectomy
12%
Public Health
18%
Quality of Life
44%
Randomized Controlled Trial
29%
Recreational Drug
6%
Renal Failure
7%
Renal Replacement Therapy
16%
Resuscitation
7%
Rheumatoid Arthritis
33%
Robot-Assisted Prostatectomy
11%
Scoping Review
9%
Sepsis
6%
Substance Use Disorder
10%
Systematic Review
61%
Thrombosis
18%
Transurethral Resection
7%
Urinary System
10%
Urologic Surgery
6%